- ►sbhh.com.br [PDF] JC Voltarelli, CEB Couri, ABPL Stracieri, MC Oliveira, … - Jama, 2007 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web standards. Find out
more about why this message is appearing and what you can do to make your experience on this site
better. ... Add to CiteULike Add ... Cited by 135 - Related articles - BL Direct - All 19 versions
- ►nih.gov KI Rother, DM Harlan - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig Worldwide, more than 750 individuals with type 1 diabetes mellitus (T1DM) have received allogeneic
islet transplants since 1974, in an effort to cure their chronic condition. Though this is still a
small number (especially when ... Cited by 103 - Related articles - BL Direct - All 11 versions
C Steele, WA Hagopian, S Gitelman, U Masharani, M … - Diabetes, 2004 - Am Diabetes Assoc Type 1 diabetes, a chronic autoimmune disease, causes destruction of insulin-producing β-cells over
a period of years. Although many markers of the autoimmune process have been described, none can
convincingly predict the rate of ... Cited by 54 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org P Fiorina, C Gremizzi, P Maffi, R Caldara, D Tavano … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—GHb levels were similar in the two groups, whereas the exogenous insulin requirement was
lower in the kidney-islet group with persistent C-peptide secretion. Overall, cardiovascular
parameters improved in the ... Cited by 44 - Related articles - All 6 versions
JM Sosenko, JP Palmer, CJ Greenbaum, J Mahon, … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Fifty-four DPT-1 participants (22 in the parenteral trial and 32 in
the oral trial) were studied. All had oral glucose tolerance tests (OGTTs) at 6-month intervals from
approximately 30 to 6 months before ... Cited by 40 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org NA Sherry, EB Tsai, KC Herold - Diabetes, 2005 - Am Diabetes Assoc Despite extensive and ongoing investigations of the immune mechanisms of autoimmune diabetes in
humans and animal models, there is much less information about the natural history of insulin
secretion before and after the ... Cited by 37 - Related articles - BL Direct - All 6 versions
B Guerci, JP Sauvanet - Diabetes and Metabolism, 2005 - Elsevier The therapeutic goal in insulin-treated diabetic patients is to maintain on the long-term a tight
glucose control (HbA1 c < 6,5-7% or less) through an insulin regimen which “mimic” the
physiological insulin profile: a ... Cited by 34 - Related articles - BL Direct - All 3 versions
J Wahren - Clinical physiology and functional imaging, 2004 - interscience.wiley.com In contrast to earlier views, new data indicate that proinsulin C-peptide exerts important
physiological effects and shows the characteristics of an endogenous peptide hormone. C-peptide in
nanomolar concentrations binds ... Cited by 30 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org E Örtqvist, E Björk, M Wallensteen, J Ludvigsson, J … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—Diazoxide decreased circulating C-peptide concentrations by ∼50%. After cessation of the
treatment, basal and meal-stimulated C-peptide concentrations increased to a maximum at 6 months,
followed by a decline. ... Cited by 30 - Related articles - BL Direct - All 6 versions
R Mussmann, M Geese, F Harder, S Kegel, U … - Journal of Biological …, 2007 - ASBMB Recent developments indicate that the regeneration of beta cell function and mass in patients with
diabetes is possible. A regenerative approach may represent an alternative treatment option relative
to current diabetes therapies that ... Cited by 30 - Related articles - All 7 versions
